» Articles » PMID: 30479022

Increased Expression of L-plastin in Nasal Polyp of Patients with Nonsteroidal Anti-inflammatory Drug-exacerbated Respiratory Disease

Abstract

Background: Most patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease (NERD) suffer from recurrence of nasal polyps. However, little is known about the specific cellular and molecular mechanisms contributing to the pathogenesis of nasal polyp development in patients with NERD in particular, especially at baseline when cyclooxygenase 1 inhibitors are not present. The objectives of this study were to identify proteins involved in the pathogenesis of nasal polyps in patients with NERD.

Methods: We collected nasal polyp tissue from patients with NERD and from patients with aspirin-tolerant chronic rhinosinusitis with nasal polyps (CRSwNP). Protein profiles were analyzed by 2-dimensional electrophoresis and identified several proteins, including L-plastin, as highly expressed. We examined L-plastin and tissue factor (TF) expression by immunohistochemical and immunofluorescence analyses. To examine the role of L-plastin in eosinophils, we knocked down L-plastin expression in Eol-1 cells by using siRNA transfection.

Results: L-plastin protein levels in nasal polyp tissue were increased in patients with NERD relative to those in patients with aspirin tolerant CRSwNP. Immunofluorescence analysis revealed that L-plastin was dominantly expressed in eosinophils and L-plastin and TF were co-expressed in eosinophils in NERD nasal polyp tissue. Knockdown of L-plastin in Eol-1 cells disrupted the cell surface distribution of TF by stimulation with granulocyte macrophage colony-stimulating factor.

Conclusion: Increased expression of L-plastin by eosinophils may contribute to abnormal fibrin deposition through TF translocation to the eosinophil cell surface in NERD nasal polyp tissue, which in turn may contribute to the pathogenesis of NERD.

Citing Articles

Allergic Bronchopulmonary Aspergillosis/Mycosis: An Allergic Disease or an Eosinophilic Disease?.

Asano K, Oguma T Intern Med. 2024; 64(4):493-501.

PMID: 39231658 PMC: 11904459. DOI: 10.2169/internalmedicine.4386-24.


The interplay of inflammation and remodeling in the pathogenesis of chronic rhinosinusitis: current understanding and future directions.

Gong X, Han Z, Fan H, Wu Y, He Y, Fu Y Front Immunol. 2023; 14:1238673.

PMID: 37771597 PMC: 10523020. DOI: 10.3389/fimmu.2023.1238673.


Studies on activation and regulation of the coagulation cascade in chronic rhinosinusitis with nasal polyps.

Cao P, Wang B, Norton J, Suh L, Carter R, Stevens W J Allergy Clin Immunol. 2022; 150(2):467-476.e1.

PMID: 35271862 PMC: 9378351. DOI: 10.1016/j.jaci.2022.02.018.


Elevated Serum Leptin Levels in Patients With Eosinophilic Chronic Rhinosinusitis.

Imoto Y, Ueki S, Kato Y, Yoshida K, Morikawa T, Kimura Y Front Pharmacol. 2022; 12:793607.

PMID: 35046816 PMC: 8762296. DOI: 10.3389/fphar.2021.793607.


Innate immune cell dysregulation drives inflammation and disease in aspirin-exacerbated respiratory disease.

Eid R, Yan C, Stevens W, Doherty T, Borish L J Allergy Clin Immunol. 2021; 148(2):309-318.

PMID: 34364539 PMC: 8363117. DOI: 10.1016/j.jaci.2021.06.016.


References
1.
Takabayashi T, Imoto Y, Sakashita M, Kato Y, Tokunaga T, Yoshida K . Nattokinase, profibrinolytic enzyme, effectively shrinks the nasal polyp tissue and decreases viscosity of mucus. Allergol Int. 2017; 66(4):594-602. DOI: 10.1016/j.alit.2017.03.007. View

2.
de Boer J, Majoor C, Veer C, Bel E, van der Poll T . Asthma and coagulation. Blood. 2012; 119(14):3236-44. DOI: 10.1182/blood-2011-11-391532. View

3.
Bachert C, Gevaert P, Holtappels G, Cuvelier C, Van Cauwenberge P . Nasal polyposis: from cytokines to growth. Am J Rhinol. 2000; 14(5):279-90. DOI: 10.2500/105065800781329573. View

4.
Laidlaw T, Kidder M, Bhattacharyya N, Xing W, Shen S, Milne G . Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood. 2012; 119(16):3790-8. PMC: 3335383. DOI: 10.1182/blood-2011-10-384826. View

5.
Fokkens W, Lund V, Mullol J, Bachert C, Alobid I, Baroody F . European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012; 23. View